Pictet Asset Management Holding Sa Moon Lake Immunotherapeutics Transaction History
Pictet Asset Management Holding Sa
- $93.5 Billion
- Q2 2025
A detailed history of Pictet Asset Management Holding Sa transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 147,721 shares of MLTX stock, worth $1.46 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
147,721
Previous 322,114
54.14%
Holding current value
$1.46 Million
Previous $12.6 Million
44.6%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding MLTX
# of Institutions
158Shares Held
54.5MCall Options Held
799KPut Options Held
661K-
Bvf Inc San Francisco, CA19.8MShares$195 Million36.63% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$84 Million40.43% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.15MShares$41 Million3.57% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.61MShares$25.8 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.67MShares$16.6 Million0.01% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $365M
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...